NONOF - Novo Nordisk to test obesity drugs including Wegovy in alcohol use
2024-05-14 14:42:53 ET
More on Novo Nordisk
- The FTC Cracks Down On Novo Nordisk's Ozempic
- Novo Nordisk A/S 2024 Q1 - Results - Earnings Call Presentation
- Novo Nordisk A/S (NVO) Q1 2024 Earnings Call Transcript
- Novo Nordisk: Patients on Wegovy maintain weight loss over four years
- Novo Nordisk hemophilia candidate Mim8 meets primary goals in phase 3 trial